Impact of Heart Failure Etiology on Waitlist Mortality in Heart Transplant Candidates Supported With Extracorporeal Membrane Oxygenation

Author:

Shah Manuj M.1ORCID,Rodriguez Emily1ORCID,Shou Benjamin L.1ORCID,Jenkins Reed T.1ORCID,Rando Hannah1ORCID,Kilic Ahmet1ORCID

Affiliation:

1. Division of Cardiac Surgery Department of Surgery Johns Hopkins Hospital Baltimore Maryland USA

Abstract

AbstractBackgroundExtracorporeal membrane oxygenation (ECMO) has gained traction as a bridge to heart transplantation (HT) but remains associated with increased waitlist mortality. This study explores whether this risk is modified by underlying heart failure (HF) etiology.MethodsUsing the Organ Procurement and Transplantation Network registry, we conducted a retrospective review of first‐time adult HT candidates from 2018 through 2022. Patients were categorized as “ECMO”, if ECMO was utilized during the waitlisting period, or “No ECMO” otherwise. Patients were then stratified according to the following HF etiology: ischemic cardiomyopathy (CMP), dilated nonischemic CMP, restrictive CMP, hypertrophic CMP, and congenital heart disease (CHD). After baseline comparisons, waitlist mortality was characterized for ECMO and HF etiology using the Fine–Gray regression.ResultsA total of 16 143 patients were identified of whom 7.0% (n = 1063) were bridged with ECMO. Compared to No ECMO patients, ECMO patients had shorter waitlist durations (46.3 vs. 185.0 days, < 0.01) and were more likely to undergo transplantation (75.3% vs. 70.3%, < 0.01). Outcomes analysis revealed that ECMO was associated with increased mortality risk (subdistribution hazard ratio [SHR]: 3.42, < 0.01), a risk that persisted in all subgroups and was notably high in CHD (SHR: 4.83, < 0.01) and hypertrophic CMP (SHR: 9.78, < 0.01). HF etiology comparison within ECMO patients revealed increased mortality risk with CHD (SHR: 3.22, < 0.01). Within No ECMO patients, hypertrophic CMP patients had lower mortality risk (SHR: 0.64, p = 0.03).ConclusionsThe increased waitlist mortality risk with ECMO persisted after stratification by HF etiology. These findings can help decision‐making surrounding candidacy for cannulation and prognostic evaluation.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3